StockNews.com started coverage on shares of Global Cord Blood (NYSE:CO – Free Report) in a research report report published on Sunday. The firm issued a strong-buy rating on the medical research company’s stock.
Global Cord Blood Price Performance
Shares of NYSE:CO opened at $1.25 on Friday. Global Cord Blood has a 1 year low of $2.03 and a 1 year high of $5.50. The business’s 50-day moving average is $1.61 and its 200-day moving average is $1.38. The company has a market capitalization of $151.94 million, a price-to-earnings ratio of 1.95 and a beta of 0.16.
About Global Cord Blood
Recommended Stories
- Five stocks we like better than Global Cord Blood
- Manufacturing Stocks Investing
- Taiwan Semiconductor Stock: Buy Now or Wait for Earnings?
- How to Calculate Stock Profit
- Abbott’s Growth and Dividends Make It a Smart Portfolio Pick
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Citigroup Faces Growing Troubles: Could the Industry Be at Risk?
Receive News & Ratings for Global Cord Blood Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Cord Blood and related companies with MarketBeat.com's FREE daily email newsletter.